Loading...
Australian Trademark — IP Australia
SITAGLIPTIN/METFORMIN XR MK
Application 2464388 · Dead / Expired
Quick Facts
| Application Number | 2464388 |
| Status | Dead / Expired |
| Owner | mankind pharma limited |
| Type | trade_mark |
| Filed | 2024-07-08 |
| Expires | 2025-04-15 |
Is this trademark active?
SITAGLIPTIN/METFORMIN XR MK has a current status of Dead / Expired. The mark is no longer active and the identifier may be available for new applications.
Prosecution Timeline
Key events recorded against this trademark at IP Australia, oldest first.
- Received by IP Australia: 2024-07-08
- Published: 2024-07-08
- Filed: 2024-07-08
- Accepted for registration: 2024-10-24
- Lapsed: 2025-04-15
- Renewal due: 2025-04-15
Applicant
| Name | mankind pharma limited |
| Country | IN |
Representative
This trademark is represented by gadens lawyers, VIC, AU.
About This Trademark
'SITAGLIPTIN/METFORMIN XR MK' is a lapsed trademark on the IP Australia register, owned by mankind pharma limited. The application (2464388) was filed on 8 July 2024. The registration is set to expire on 15 April 2025.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
Frequently Asked Questions
Who owns Australian trademark 2464388 ('SITAGLIPTIN/METFORMIN XR MK')?
Australian trademark 2464388 for the mark 'SITAGLIPTIN/METFORMIN XR MK' in Class 5 is recorded on the IP Australia register as owned by mankind pharma limited. This covers one specific Australian trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is Australian trademark 2464388 currently a registered trademark?
No — the IP Australia records the status of Australian trademark 2464388 for the mark 'SITAGLIPTIN/METFORMIN XR MK' as lapsed.
Which goods or services does Australian trademark 2464388 cover?
Australian trademark 2464388 for the mark 'SITAGLIPTIN/METFORMIN XR MK' is registered in Class 5, which covers pharmaceuticals & medical preparations.
When was Australian trademark 2464388 filed?
Australian trademark 2464388 for the mark 'SITAGLIPTIN/METFORMIN XR MK' was filed at the IP Australia on 8 July 2024.
When does Australian trademark 2464388 need to be renewed?
Australian trademark 2464388 for the mark 'SITAGLIPTIN/METFORMIN XR MK' is currently recorded as valid until 15 April 2025, at which point it will need to be renewed with the IP Australia to remain in force.
Data Source
Australia (IP Australia)
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.